• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

And the Hits Just Keep on Coming...





I have heard of setting the bar low but in Spermin' Herman's case, he sets it to zero.

It is entertaining but republican primary voters must be getting tired of this demonstration of ignorance and the stupidity to cover it up.

Cain has gone from arrogant, to offensive, to downright embarrassing.

His campaign has now entered the realm of the absurd, the surreal.

Pass the popcorn.